Loss of quinidine gluconate injection in a polyvinyl chloride infusion system

被引:4
作者
Darbar, D
DellOrto, S
Wilkinson, GR
Roden, DM
机构
[1] VANDERBILT UNIV,SCH MED,DIV CLIN PHARMACOL,DEPT MED,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232
关键词
absorption; additives; adsorption; blood levels; cardiac drugs; concentration; containers; dextrose; diethylhexyl phthalate; diluents; drug administration routes; drugs; availability; incompatibilities; injections; leaching; pharmacokinetics; photodecomposition; polyvinyl chloride; quinidine sulfate; quinidine gluconate; stability; surgical supplies; tubing;
D O I
10.1093/ajhp/53.6.655
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of a polyvinyl chloride (PVC) i.v. administration system on the availability of quinidine gluconate was studied. Quinidine gluconate diluted in 5% dextrose injection was administered intravenously to five healthy volunteers via conventional PVC infusion sets, and the subjects received oral quinidine sulfate two days later. The mean +/- S.D. oral bioavailability of quinidine was, un unexpectedly, greater than 100% (147 +/- 44%). To test the possibility that this occurred because of reduced delivery of i.v. quinidine, the percentage of drug delivered via two systems was evaluated in simulation studies, one involving a conventional PVC administration set and the other a glass syringe attached to shorter PVC tubing and a winged i.v. catheter. Spectrophotometric analysis revealed a 5-7% reduction in absorbance associated with loss of quinidine in the PVC infusion bag and a further 34-38% reduction in absorbance attributable to quinidine loss in the PVC tubing. However, with the winged i.v. catheter system the loss was reduced to less than 3%. More than 40% of a dose of quinidine gluconate was lost when the drug was administered with a conventional PVC i.v. administration set. Drug loss was reduced by using a winged i.v. catheter and shorter tubing.
引用
收藏
页码:655 / 658
页数:4
相关论文
共 21 条
  • [1] NITROGLYCERIN COMPATIBILITY WITH INTRAVENOUS FLUID FILTERS, CONTAINERS, AND ADMINISTRATION SETS
    BAASKE, DM
    AMANN, AH
    WAGENKNECHT, DM
    MOOERS, M
    CARTER, JE
    HOYT, HJ
    STOLL, RG
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (02): : 201 - 205
  • [2] INTERACTION BETWEEN VITAMIN-A AND PLASTIC INTRAVENOUS FLUID BAGS
    CHIOU, WL
    MOORHATC.P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 223 (03): : 328 - 328
  • [3] EFFECT OF VARIOUS FACTORS ON AMOUNT OF PLASTICIZER IN INTRAVENOUS SOLUTIONS PACKAGED IN FLEXIBLE BAGS
    CORLEY, JH
    NEEDHAM, TE
    SUMMER, ED
    MIKEAL, R
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (03): : 259 - 264
  • [4] DITLEFSEN EML, 1953, ACTA MED SCAND, V146, P81
  • [5] DRAYER DE, 1978, CLIN PHARMACOL THER, V34, P31
  • [6] Gibaldi M., 1982, PHARMACOKINETICS, P409
  • [7] Graham P R, 1973, Environ Health Perspect, V3, P3, DOI 10.2307/3428023
  • [8] GREENBLATT DJ, 1977, J PHARMACOL EXP THER, V202, P365
  • [9] QUINIDINE PHARMACOKINETICS IN MAN - CHOICE OF A DISPOSITION MODEL AND ABSOLUTE BIOAVAILABILITY STUDIES
    GUENTERT, TW
    HOLFORD, NHG
    COATES, PE
    UPTON, RA
    RIEGELMAN, S
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (04): : 315 - 330
  • [10] CLINICAL PHARMACOKINETICS OF ANTIARRHYTHMIC DRUGS
    HARRISON, DC
    MEFFIN, PJ
    WINKLE, RA
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1977, 20 (03) : 217 - 242